Company
Vibe Bioscience Ltd
Headquarters: Vancouver, BC, Canada
CEO: Mr. Mark William Waldron
No stock data available
Market Cap
C$2.8 Million
CAD as of Jan. 1, 2024
US$2.1 Million
Vibe Bioscience Ltd Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Vibe Growth Corporation engages in the cultivation, production, retail, and distribution of cannabis for recreation and medicinal use in the United States, Canada, and internationally. It operates seven dispensaries and a cannabis greenhouse cultivation, as well as sells its products online under the Vibe By California brand. The company was formerly known as Vibe Bioscience Ltd. and changed its name to Vibe Growth Corporation in October 2020. Vibe Growth Corporation was incorporated in 2011 and is headquartered in Vancouver, Canada.
Top 1-year algo backtest: +181.22%
$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Vibe Bioscience Ltd has the following listings and related stock indices.
Stock: CSE: VIBE wb_incandescent